MedPath
NMPA Approval

Bendamustine Hydrochloride for Injection

国药准字H20213967

December 31, 2021

Drug Information

注射用盐酸苯达莫司汀

注射剂

25mg(以C16H21Cl2N3O2·HCl计)

化学药品

December 31, 2021

Company Information

Applicant Company

江苏省泰州市扬子江南路1号

Manufacturing Company

江苏省泰州市扬子江南路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用盐酸苯达莫司汀 - NMPA 批准文号 | MedPath